 Connection
Jason Farrar to Promoter Regions, Genetic
This is a "connection" page, showing publications Jason Farrar has written about Promoter Regions, Genetic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.071 |
|
|
|
-
Gore L, Triche TJ, Farrar JE, Wai D, Legendre C, Gooden GC, Liang WS, Carpten J, Lee D, Alvaro F, Macy ME, Arndt C, Barnette P, Cooper T, Martin L, Narendran A, Pollard J, Meshinchi S, Boklan J, Arceci RJ, Salhia B. A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML. Clin Epigenetics. 2017; 9:108.
Score: 0.032
-
Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, Ko DC, Zou Y, Bang ND, Chau TT, Vary JC, Hawn TR, Dunstan SJ, Farrar JJ, Thwaites GE, King MC, Serhan CN, Ramakrishnan L. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 2012 Feb 03; 148(3):434-46.
Score: 0.021
-
Nguyen TH, Mai NL, Le TP, Ha V, Nguyen TC, Tran TH, Nguyen TH, Farrar JJ, Dunstan SJ. Toll-like receptor 4 (TLR4) and typhoid fever in Vietnam. PLoS One. 2009; 4(3):e4800.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|